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Multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous
system (CNS) is the leading cause of non-traumatic neurological disability in young
adults. Immune mediated destruction of myelin and oligodendrocytes is considered
the primary pathology of MS, but progressive axonal loss is the major cause of
neurological disability. In an effort to understand microglia function during CNS
inflammation, our laboratory focuses on the fractalkine/CX3CR1 signaling as a regulator
of microglia neurotoxicity in various models of neurodegeneration. Fractalkine (FKN) is
a transmembrane chemokine expressed in the CNS by neurons and signals through
its unique receptor CX3CR1 present in microglia. During experimental autoimmune
encephalomyelitis (EAE), CX3CR1 deficiency confers exacerbated disease defined by
severe inflammation and neuronal loss. The CX3CR1 human polymorphism I249/M280
present in ∼20% of the population exhibits reduced adhesion for FKN conferring
defective signaling whose role in microglia function and influence on neurons during
MS remains unsolved. The aim of this study is to assess the effect of weaker
signaling through hCX3CR1I249/M280 during EAE. We hypothesize that dysregulated
microglial responses due to impaired CX3CR1 signaling enhance neuronal/axonal
damage. We generated an animal model replacing the mouse CX3CR1 locus for the
hCX3CR1I249/M280 variant. Upon EAE induction, these mice exhibited exacerbated EAE
correlating with severe inflammation and neuronal loss. We also observed that mice
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with aberrant CX3CR1 signaling are unable to produce FKN and ciliary neurotrophic
factor during EAE in contrast to wild type mice. Our results provide validation of
defective function of the hCX3CR1I249/M280 variant and the foundation to broaden the
understanding of microglia dysfunction during neuroinflammation.
Keywords: EAE (experimental autoimmune encephalitis), fractalkine receptor, microglia, multiple sclerois and
neuroimmunology, demyelination and neuronal damage

INTRODUCTION

be associated with increased frequencies of IL-17 or IFN-γ
producing MOG35−55 specific T cells, as revealed by comparable
proportions of IFN-γ and IL-17 producing T cells in WT,
CX3CR1-KO and CX3CR1I249/M280 draining lymph nodes at
11 days post-immunization. CD4+ T cells represented the
predominant population expressing IL-17 or IFN-γ, with
negligible detection of IL-17/IFN-γ double positive cells in
intracellular cytokine image flow cytometry assays. In CNS
tissues, analyses of inflammatory cells revealed comparable
levels of infiltration of dendritic cells (DCs), neutrophils
and CD4+ T cells, however, CX3CR1I249/M280 mice displayed
increased frequencies of CD45Lo /CD11b+ microglia and CD8+
T cells. Transcriptional analyses revealed several genes highly
upregulated in all genotypes but of particular interest was
lipocalin 2, and immunostaining confirmed its significant
upregulation in WT tissues compared to CX3CR1-KO and
CX3CR1I249/M280 brains. Overall these results indicate that
CX3CR1I249/M280 expressing mice exhibit an EAE phenotype that
closely resembles the phenotype of CX3CR1-KO mice. These
findings highlight the neuroprotective effects of FKN during EAE
and provide a potential novel pathway to understand how LCN2
could be targeted to control inflammation and promote repair,
based on its regulation by CX3CR1/FKN signaling.

Inflammatory demyelination is a hallmark of the pathology of
multiple sclerosis (MS) and microglia are considered responsible
for exacerbating myelin loss. Although the link between
microglia mediated inflammation and neurodegeneration is
being increasingly recognized, the mechanisms that connect
microglia, inflammation, and demyelination are unclear.
Our previous studies have shown that the neuronal derived
chemokine, fractalkine (FKN, also formally known as CX3CL1),
and its unique receptor, CX3CR1, expressed by microglia, are
highly abundant in the healthy brain and spinal cord and have
direct roles in inhibiting microglia inflammatory behavior
(Cardona et al., 2006). Notably, demyelination and neuronal
damage are exacerbated in mice lacking CX3CR1 (Garcia
et al., 2013) suggesting that microglia exert anti-inflammatory
roles during demyelination. In humans, two single nucleotide
polymorphisms in the CX3CR1 locus produce receptors with
proposed defective binding to FKN and appear to play a
deleterious role in MS progression. Most individuals carry the
CX3CR1V249/T280 allele, while the variant CX3CR1I249/M280
is present in 25–30% of the population. Cells expressing
CX3CR1I249/M280 are less responsive to FKN (McDermott
et al., 2003) and in a small cohort of patients, the CX3CR1M280
mutation was found preferentially associated with secondary
progressive MS in which patients develop more demyelinated
lesions (Stojkovic et al., 2012). However, the role of the human
variant CX3CR1M280 in microglia distribution, in modulating
central nervous system (CNS) inflammation, and demyelination
in MS models has not been directly addressed.
Due to the proposed defect of the human CX3CR1I249/M280
variant in signaling to FKN, we sought to determine how
closely the expression of the human variant recapitulates the
phenotype observed in CX3CR1-deficient mice. For this, we
generated a model in which mice in the C57BL6 background
express the I249/M280 variant of the human CX3CR1 receptor
in lieu of the murine counterpart. In this study, we report the
phenotype of CX3CR1I249/M280 expressing mice under active
disease in myelin oligodendrocyte glycoprotein (MOG35−55 )
induced experimental autoimmune encephalomyelitis (EAE).
We describe disease progression, CNS cellular infiltration,
demyelination, neuronal loss, and expression of inflammationassociated genes. Our results show that EAE progression is
more severe in CX3CR1I249/M280 mice than WT mice and
closely resembles the disease course observed in CX3CR1-KO
mice. More severe demyelination and neuronal loss was also
observed in CX3CR1I249/M280 mice, particularly in cerebellar
regions. Differences in disease severity did not appear to
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MATERIALS AND METHODS
Chemotactic Assay
Responsiveness of human CX3CR1 receptors to mouse
fractalkine was tested in vitro using bone marrow derived
macrophages grown on poly-D-lysin coated flasks in complete
RPMI media (20% FBS, 2 mM glutamine, 100 µg/mL
streptomycin, 100 U/mL penicillin, and 40 ng/mL rhu-MCSF) for 4 days and electroporated with 2 µg of pIRES2
expression plasmid containing the human CX3CR1 ORF for the
reference hCX3CR1V249/TM280 or hCX3CR1I249/M280 genes. Cells
were expanded for 3 days in complete media and the number
of cells that mobilized across a millicell PCF 8 µm insert were
quantified by virtue of RFP expression from expressing vector
and DAPI nuclear staining. Five images at 20x were acquired per
insert and cells were quantified. Data was reported as number of
cells per mm2 .

Molecular Cloning and Generation of
hCX3CR1I249/M280 Mice
Genomic fragments of the murine CX3CR1 locus were
isolated from the pEasyFlox-CX3CR1-eGFP targeting vector
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paralysis, 4: tetraplegia, and 5: death. Mice were sacrificed when
they reached the highest disease score (peak of disease, 16–21
d.p.i) or 2–3 weeks after peak (chronic phase).

(Jung et al., 2000) by PCR to construct a targeting vector on the
pEasyFLox backbone containing the 50 untranslated region [short
arm (SA)] of mouse CX3CR1, variant CX3CR1I249/M280 complete
open reading frame (ORF), a neomycin gene within lox P sites,
and the 30 untranslated region of mouse CX3CR1 [long arm
(LA)]. A genomic fragment containing the hCX3CR1I249/M280
ORF was subcloned from plasmid pSC59 (McDermott et al.,
2003). The homologous regions of the final vector consisted of
a PCR amplified 1.2 Kb fragment (SA) immediately upstream
of the hCX3CR1 start codon, a 7.0 Kb fragment spanning the
30 mouse CX3CR1 UTR (LA), and selection markers of the
pEasyFlox cloning vector. Hybrid C57BL/6–129 embryonic
stem cells were expanded and electroporated with the NotI
linearized vectors (The University of Texas MD Anderson
Cancer Center Genetically Engineered Mouse Facility). After
selection with G418 and FIAU, surviving clones were grown
and DNA was isolated. Southern blots were used to confirm
homologous recombination at 50 and 30 end utilizing probes
specific for mouse genome loci (SAprobe3 and LAprobe 3).
Germ line transmission yielded hCX3CR1I249/M280 mice that
were backcrossed (>N6) to C57BL/6 mice. Cx3cr1 transcript
levels were assessed in microglia sorted from WT, KO, and
hCX3CR1I249/M280 mice. Mice were genotyped by polymerase
chain reaction (PCR) using specific primers to identify not
only insertion of the human cx3cr1 gene but also locus specific
insertion: SA-13: 50 -CCAAGACAGAATTTCACTGTGTAGC30 ;
SA-14:
50 -CAACAAATTTCCCACCAGGCCAATG-30 ;
SA-15: 50 -TACCTGGCCATCGTCCTGGCCGCCA-30 ; SA-16:
50 -ACGAGACTAGTGAGACGTGCTACTT-30 . Crossing of
these mice with B6.FVB-TG (EIIa-cre)C5379Lmgd/J (The
Jackson Laboratory, Stock No. 003724) resulted in cre-mediated
recombination of the floxed neomycin resistance gene, removal
of the stop cassette, and concomitant loss of the SA-15/SA-16
1,004 bp fragment and subsequent expression of the hCX3CR1
unit. Validation of the introduction of the human gene and
respective I249/M280 mutation was further confirmed by
sequencing.

Antibodies
For immunohistochemistry experiments, tissues were stained
with primary antibodies directed to identify microglia (rabbit
anti-Iba-1, 1:4000, Wako or mouse anti-Iba-1 kindly provided
by Dr. Bruce Trapp), inflammatory monocytes (rat anti-CD45,
1:2000, Bio-Rad), cerebellar neurons (rabbit anti-calbindin,
1:1000, Cell signaling Technology), pro-inflammatory cytokine
interleukin-1 beta (rabbit anti-IL1 beta, 1:200, abcam), myelin
basic protein (MBP) (rabbit anti-MBP, 1:2000, Invitrogen),
and astrocytes (rat anti-GFAP, 1:4000, Invitrogen). Secondary
antibodies were purchased from Jackson ImmunoResearch
Laboratory as follows: Cy3-goat anti rabbit, Cy5-donkey
anti rat, Cy2-goat anti mouse, biotinylated-goat anti rabbit,
biotinylated-goat anti mouse, and biotinylated-rabbit anti rat.
Biotinylated antibodies are detected by using stable DAB
(Thermo Fisher Scientific) containing diaminobenzidine and
hydrogen peroxidase.

Immunohistochemistry Staining of CNS
Tissues

C57BL/6J wild type (WT) and CX3CR1GFP/GFP mice were
purchased from The Jackson laboratory (Bar Harbor, ME,
United States), hCX3CR1I249/M280 were backcrossed to C57BL/6J
background for seven generations. Mice were maintained at the
Laboratory Animal Resource Center at the University of Texas at
San Antonio. All experiments were performed in accordance with
NIH guidelines and approved by UTSA-Institutional Animal
Care and Use Committee.

Mice were placed under deep anesthesia with 5% isoflurane
in an induction chamber and sacrificed by perfusion with ice
cold Hanks balanced salt solution (HBSS w/o Ca++ , Mg++ ,
Lonza) followed by 4% PFA. Dissected brains were post-fixed
overnight in 4% PFA and cryoprotected in 20% glycerol in
80mM phosphate buffer (pH 7.6) for at least 24 h. Free floating
sections (30 µm) were generated using a freezing microtome
and stored at −20◦ C until use. For immunostaining, tissues were
blocked and permeabilized with 10% normal goat or donkey
serum (Jackson ImmunoResearch) containing 0.3% Triton X100 (Sigma) for 1 h at room temperature. Primary antibodies
were incubated overnight at 4◦ C. Tissues were washed in PBS
supplemented with 0.1% Triton X-100 and incubated with hostappropriate secondary antibodies for 2 h at room temperature.
Tissues were then mounted onto superfrost plus slides, allowed
to air dry and baked at 50◦ C for 20 min. For quantification of
myelin content and calbindin and IBA-1 immunoreactivity three
tissue sections per mouse were stained and eight random images
per sections were acquired. Individual cells were counted using
the count analysis tool in Adobe Extended CS6v13 (Adobe) and
immunoreactive area obtained in Image J as previously described
(Mendiola et al., 2017).

Induction of Active EAE

Flow Cytometry and Cell Sorting

Active EAE was induced in female mice 8–10 weeks old by
subcutaneous immunization with 100 µg of MOG35−55 peptide
in CFA, and 200 ng of pertussis toxin on days 0 and 2 postimmunization as previously described (Garcia et al., 2013). Mice
were weighed and examined daily for EAE signs and scored
according to the following scale: 0: no sign of disease, 1: lack of
tail tone, 2: abnormal gait and/or hind limb weakness, 2.5: partial
hindlimb paralysis, 3: complete hindlimb paralysis, 3.5: ascending

Mononuclear cells were isolated from brain and spinal cord
of CX3CR1-WT, CX3CR1-KO, and hCX3CR1I249/M280 mice
by homogenization of CNS tissues as previously described
(Pino and Cardona, 2011). Cellular suspensions were blocked
using anti-mouse CD16/CD32 (clone 2.4G2, BD Pharmingen)
followed by incubation for 30 min with a mix of fluorochromeconjugated anti-mouse antibodies as follows. Antibody cocktail
for mononuclear myeloid cells and activation markers: CD45

Mice
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APC-Cy7 (clone 30-F11, BioLegend), CD11b PE-CF594
(clone M1/70, BD Biosciences), CD11c PE-Cy7 (clone N418,
eBioscience), I-A/I-E BV421 (MHC-II clone M5/114.15.2, BD
Biosciences), CD86 PerCP/Cy5.5 (clone GL-1, BioLegend), Ly6C
AF647 (clone ER-MP20, Serotec), Ly6G PE (clone 1A8, BD
Pharmingen). T cells were characterized using the following
antibody mix: CD45 eFluor 450 (clone 30-F11, eBioscience),
CD3e PE-Cy7 (clone 145-2C11, BioLegend, CD8a APC (clone
53-6.7, eBioscience), CD4 APC-Cy7 (clone RM4-5, BioLegend),
CD44 PerCP (clone IM7, eBioscience). Samples were acquired
on an LSRII (BD Biosciences) at the Cell Analysis Core, UTSA.
Data analysis was performed using FlowJo v10. For cell sorting,
brain cell suspensions (pooled 3 mice per sample) were stained
with antibodies against CD45 and CD11b and after gating for
single cells the CD45Lo CD11b+ population was separated in a
FACS ARIA-II (BD Biosciences).

were made in lysis buffer containing 150 mM NaCl, 10 mM TrisBase, 1 mM EDTA pH 8.0 and 1X protein inhibitor cocktail
(Roche). Lysates were centrifuged at 12,000 rpm for 15 min at
4◦ C, aliquoted and stored at −80◦ C. Total protein concentrations
were determined using the Bio-Rad protein reagent assay (BioRad) and quantities of soluble factors were measured by enzymelinked immunosorbent assay (ELISA) using the following kits:
DuoSet ELISA development system (R&D Systems) for mouse
CX3CL1/Fractalkine, DuoSet ELISA development system (R&D
Systems) for mouse IL-1b/IL-1F2 and ELISA kit (CUSABIO)
for the mouse CNTF. Samples were run in duplicate. Results
were normalized to total protein and reported in picogram (pg)
amounts per milligram (mg) of protein as previously described
(Cardona et al., 2015).

Intracellular Staining and Imaging Flow
Cytometry

Total RNA (100 ng) from cerebellar extracts at chronic EAE
was used to analyze gene expression changes using nCounter
and nSolver 3.0 software (NanoString Technologies). Transcript
levels of 582 genes were assessed with the nCounter GE-Mouse
Immunology v1 Kit (NanoString Technologies) performed by
the Genomic and RNA Profiling Core Baylor College of
Medicine (Department of Advanced Technology Cores). Data
were initially normalized using positive and negative controls and
housekeeping specific probes (Mendiola et al., 2017). Samples
were then further normalized within nSolver to naïve groups.
Differentially expressed genes were defined by a cutoff of ±2fold change and p < 0.05. For RNA sequencing, sorted cells
were subjected to total RNA extraction using the PicoPure
RNA isolation kit (Arcturus), libraries were obtained from the
genome sequencing facility (Greehey Children’s Cancer Research
Institute – UT Health San Antonio). Raw reads were imported
into CLC Genomics Workbench v10.1.1. Initially, low quality
reads were trimmed; remaining reads for each sample were
mapped to the annotated mouse genome (GRCm38), followed
by differential gene expression (DGE) analysis of EAE samples
from CX3CR1-WT, CX3CR1-KO, and hCX3CR1I249/M280 mice
against their respective naïve controls using the RNA-seq tool
within CLC Genomics Workbench software. Genes were deemed
to be differentially expressed if the false discovery rate (FDR) was
0.05 or less.

NanoString Gene Expression Analysis
and RNA Sequencing

To assess cytokine production on T cells infiltrating the
CNS, immunized mice were sacrificed at peak disease and
mononuclear cells from brain tissues were isolated as previously
described (Garcia et al., 2013). T cells were stimulated for 4 h
at 37◦ C and 5% CO2 under the following conditions: cRMPI
[RPMI 1640, Gibco; 10% Fetal bovine serum, Atlanta Biologicals;
1% Pen-Strep (Gibco), anti-CD3e (BioLegend), anti-CD28 (BD
Pharmingen) and GolgiStop (BD Biosciences)]. For intracellular
cytokine staining, the following reagents were used: Mouse Fc
block (clone 2.4G2, BD Pharmingen); fixation/permeabilization
buffer (Invitrogen); perm/wash buffer (BD Biosciences); cell
staining buffer (BioLegend) and the following antibody cocktail:
TCR-b V450 (clone H57-597, BD Horizon), CD4-APC-Cy7
(clone RM4-5, BioLegend), CD8a-PerCP/Cy5.5 (clone 53-6.7,
BD Pharmingen), IL-17-PE (clone TC11-18H10.1, BioLegend)
and IFN-γ-APC (clone XMG1.2, BioLegend) Samples were
acquired using an ImageStreamX-Imaging Flow Cytometer-ISXMKII (EMD Millipore) at the Cell Analysis Core, UTSA. Data
analysis was performed using IDEAS software version 6.2.

Cytokine ELISpot Assay
Mice were immunized with 100 µg MOG35−55 and sacrificed
10 days post-immunization. Inguinal lymph nodes were
harvested and cells were plated at a density of 5 × 105 per well.
Assay was performed as previously described (Garcia et al.,
2013). Plate was read and spot counted using ImmunoSPOT
software. Data are presented as spot-forming units per million of
cells.

Computational Methodology and
Molecular Modeling of CX3CR1 Protein
Search for CX3CR1 in the Protein databank RCSB (Berman et al.,
2012) provided information for the crystallized form of CCR5
identified as 4MBs (Tan et al., 2013) that was used as template
to predict the structure of CX3CR1 constructing hypothetical
models. The primary sequence of Homo sapiens CX3CR1 is
reported in the Uniprot database in FASTA format and was
used for structural prediction model (UniProt Consortium,
2012, 2014). The hypothetical structural model for CX3CR1
was obtained using the peptide and protein structure predictor
Phyre2 (Kelley and Sternberg, 2009) which belongs to the group
of structural bioinformatics at the Imperial College of London,

Enzyme-Linked Immunosorbent Assay
For the detection of soluble FKN, IL-1β and ciliary neurotrophic
factor (CNTF) in CNS tissues, mice were anesthetized with 5%
isoflurane in an induction chamber, followed by perfusion with
ice cold Hanks balanced salt solution (HBSS w/o Ca++ , Mg++ ,
Lonza). Spinal cord, cerebellum, and forebrain were dissected and
disrupted manually using dounce homogenizers. Suspensions
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anisotropy of water that, based on an stochastic focus, provides
a model to define the topology of the system (Lomize et al., 2012).

and allows an assembly by homology based on comparison
of the reported crystalized structure and primary sequences.
The predictor software includes an algorithm that favors the
identification of structural folds and via threading methodology,
assembles fragments found by similarity utilizing the atomic
backbone as a flexible system that follows the dynamic laws
of Newton in classical conceptualization (Kelley et al., 2015).
To characterize and evaluate the obtained hypothetical models,
a validation was performed using a tool from the group of
bioinformatics and crystallography RAMPAGE [8], that takes
into account the special distribution and orientation, calculating
in graph of quadrants, Phi (ϕ) and Psi (ψ) dihedral angles
of the peptide bonds that join each amino acid in the model.
Likewise, an energetic validation is performed from the suite
Swiss assessment structure as QMEAN6 (Benkert et al., 2008;
Studer et al., 2014) and Z-score with the PROSA web software
(Wiederstein and Sippl, 2007) that via comparative methodology
classifies the models based on experimentally obtained and
characterized structures, and the software then assigns a score to
select the best model for a size of 355 amino acids, corresponding
to size of CX3CR1 (Sippl, 1993). Structural viewers were used
to gain further insights into the special and tridimensional
distribution of the receptor. Deepview/Swiss-PdbViewer v3
(Guex and Peitsch, 1997) allowed us to do a preliminary
assessment and then structures were visualized in the UCSF
Chimera v1.11 (Pettersen et al., 2004) as it allows configuration of
the model as ribbon, surface, or density type based on the spatial
volume.

Statistical Analysis
Data are expressed as mean ± SEM in graphs and plots. In
scattered plots, each dot represents data from an individual
mouse. Data were plotted in GraphPad Prism 5 and statistical
comparisons performed by non-paired two-tail Student’s t-test or
One-way ANOVA followed by Tukey’s post-test when comparing
multiple groups. p-Values < 0.05 considered statistically
significant. RNA seq data was subjected to exact test comparison
of EAE tissues against their naïve counterparts. Bonferroni
and FDR corrections were applied. FDR p-values < 0.05 were
considered statistically significant.

RESULTS
Defective CX3CR1 Signaling Through
hCX3CR1I249/M280 Variant Exacerbates
Clinical EAE Disease
Data from our laboratory has shown that fractalkine/CX3CR1
signaling regulates microglia neurotoxicity in selected mouse
models of neurodegeneration (Cardona et al., 2006; Bhaskar et al.,
2010; Garcia et al., 2013; Maphis et al., 2015). To complement
those studies our laboratory has developed a new animal model
that allows the understanding of not only CX3CR1/FKN during
models of neuroinflammation, but to uniquely define the role
of the human CX3CR1 variant during MS models. For this, we
engineered a transgenic mouse in which the human CX3CR1
variant gene (hCX3CR1I249/M280 ) was introduced into the mouse
genome replacing the mouse counterpart (Figure 1). Comparison
of protein sequence between the WT and variant receptors
revealed that the T280M substitution contributes to an increase
in the hydrophobicity of the region between amino acids 275
and 290 (Figure 2A). The hydropathic index is important to
understand how the mutations in the variant receptor affect
the protein regions potentially involved in the interaction
ligand–receptor. A tridimensional model of the variant receptor
proposes an alteration in the interaction with the cellular
membrane resulting in a shift toward the intracellular space of
the alpha-helix containing the V249I substitution (Figures 2B,C).
This shift has a significant effect in the extracellular portion
of the protein as it results in the disruption of disulfide
bridges (C21–C265), thereby generating conformational changes
in the protein structure that alter CX3CR1-FKN recognition
domain which could potentially negatively affect protein function
(Supplementary Figure S1). Results indicate that after active
immunization with MOG35−55 peptide, clinical disease was more
severe in mice expressing the human CX3CR1 variant when
compared to WT mice (Figure 3A). Interestingly, the time at
which the hCX3CR1I249/M280 mice reached their highest clinical
disability (Figure 3B, peak) resembled the observations of the
CX3CR1-KO mice. Despite the fact that the maximum score
observed in the hCX3CR1I249/M280 mice showed an intermediate
value between the WT and CX3CR1-KO mice (Figure 3C), the

Bioinformatics Analysis of CX3CR1
Variant
Native CX3CR1-WT (V249/T280) and variant CX3CR1I249/M280
proteins were analyzed for hydropathic index, N-glycosylation,
and quantification of the transmembrane domain with the
hidden models of Markov. This procedure uses the primary
protein sequence in FASTA format and by selecting the Protscale
software that belongs to the Swiss ExPASY suite, the menu allows
the calculation of the hydropathic index selecting the Kyte and
Dolittle coefficients (Artimo et al., 2012) which assigns a score
to each amino acid. The index ranges from positive to negative
numbers that is equivalent to hydrophobic and hydrophilic
values respectively, with zero as the separation baseline. For
characterization of N-glycosylation of the protein we use NetGlyc
1.0 server which calculates the probability of N-glycosylation
in the sequence of amino acids Asn-Xaa-Ser/Thr (Artimo
et al., 2012). Since CX3CR1 is a seven-transmembrane domain
receptor, we performed an assessment of the transmembrane
domains with the TMHMM 2.0 Suite Swiss-ExPASy, to locate the
amino acids within the membrane and intracellular-extracellular
loops with scores obtained with “websequence” (Artimo et al.,
2012). The theoretical orientation and positioning of the protein
within the lipid bilayer is assembled with the software web PPM
server that takes into account hydrophobic interacting forces,
distances and interaction of hydrogen bonds with the aqueous
environment, bonding profiles due to the dielectric constant
of water, dipolar interaction with protein residues and the
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FIGURE 1 | Generation of mice expressing the human CX3CR1I249/M280 variant. (A) To confirm that human CX3CR1 signals effectively in response to mouse FKN,
CX3CR1-KO bone marrow derived macrophages were transfected with pIRES expression vectors expressing the respective human sequences WT (V249/T280), or
M280 (I249/M280) CX3CR1. Cells were compared in migration assays in response to various concentrations of soluble recombinant mouse fractalkine. Transfection
of vectors into KO or WT macrophages show dose dependent transmigration of cells in response to mouse recombinant FKN. Samples were run in duplicates and
data represents the average of three independent experiments. (B) Targeting construct containing the hCX3CR1I249/M280 sequence was engineered using the
pEasyflox vector harboring a 12 Kb fragment containing the 50 mouse CX3CR1 UTR (Short Arm, SA) upstream of the human CX3CR1 start codon, and a 7.0 Kb
fragment spanning the 30 mouse UTR [long arm (LA)], and targeting strategy depicting the location of probes for validation by Southern blots, and PCR genotyping.
(C) After delivery of the targeting constructs to ES cells, positive clones with successful homologous recombination were identified by Southern blots upon HincII
and AflII digestion to confirm insertion at both 50 and 30 ends with SA and LA specific probes. (D) Expression of CX3CR1 was confirmed at the transcript levels in
sorted microglial cells from corresponding, CX3CR1-WT, KO, and hCX3CR1I249/M80 n = 3 samples per group. ∗ p < 0.05.

cumulative disease score, a measure of clinical disease severity
closely resembled and reproduced previous observations from
our laboratory reporting an exacerbated phenotype in mice
lacking CX3CR1 (Figure 3D). These data support the notion of
impaired fractalkine signaling as a result of the expression of the
adhesive deficient human I249/M280 polymorphic variant.

in naïve mice (Figures 4A bottom,C). These observations
recapitulate the cerebellar pathology observed in the CX3CR1KO mice, suggesting a crucial role for defective CX3CR1
signaling in the inflammatory mediated events that lead to the
development of pathological features during MOG35−55 induced
neurodegeneration.

Expression of hCX3CR1I249/M280 Is
Associated With Severe Cerebellar
Inflammation and Neuronal Pathology

Inflammatory Response in CNS of
hCX3CR1I249/M280 Mice Is Dominated by
Macrophages and T Cells at Peak EAE

To investigate the association between clinical manifestation and
CNS pathology, we assessed infiltration and neuronal damage
in brain sections of mice sacrificed at the chronic phase of
EAE. Higher clinical scores during EAE were associated with
severe infiltration of blood-derived inflammatory cells to the
CNS and their actions on axonal fibers that lead to the ataxia
and paraplegia observed in the time course of the disease.
Persistent extravasation of inflammatory cells, particularly into
the cerebellum of immunized mice, are depicted by the increase
in CD45 staining upon EAE induction (Figure 4A, top).
Severe inflammation in mice expressing the hCX3CR1I249/M280
receptor correlated with significant decrease in calbindin+
cells in the cerebellum (Figures 4A middle,B) based on the
quantification of neurons in the Purkinje cell layer and its
comparison to immunized WT mice. Neuronal loss in CX3CR1KO and hCX3CR1I249/M280 mice correlated with worsened
demyelination identified by the loss of MBP staining in the
cerebellar white matter when compared with myelin staining

Analysis of the inflammatory response in EAE affected brains by
flow cytometry analysis (Figure 5A) reveals a higher proportion
of CD45Hi cells at peak disease (Figure 5B) compared to
chronic stages when CD45Lo /CD11b+ microglia appear as the
predominant cell population (Figure 5C). Interestingly, the
proportion of microglia at peak EAE in hCX3CR1I249/M280
mice slightly exceeded what was observed in CX3CR1KO mice (Figure 5B). Assessment of myeloid populations
revealed CD45Hi CD11b+ Ly6C+ Ly6G− CD11c− macrophages
(Figure 5A) as the most abundant myeloid cells in the brain of
EAE-induced mice both at peak and chronic EAE (Figures 5D,E),
regardless of the CX3CR1 genotype. Also, comparable levels
of CD45Hi CD11b+ Ly6G− Ly6C− CD11c+ myeloid derived
dendritic cells (mDCs) (Figure 5A) were observed during
chronic EAE (Figure 5E) across all genotypes. Flow cytometry
analyses were also conducted in spinal cord tissues to classify the
components of the inflammatory response in hCX3CR1I249/M280
mice (Figure 6A). Severe infiltration, reflected by the close to 70%
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FIGURE 2 | CX3CR1 hypothetical tridimensional model. (A) The hydropathic index provides information on the effects of amino acid changes to the chemical
environment of the protein. The index based on the coefficients of Kyte and Dolittle show that there is an increase in the hydrophobicity in the region with the change
T280M. (B) The orientation and position of the protein within the lipid bilayer is assembled with software web PPM and (C) the aligned hypothetical models of the
human-reference receptor and mouse CX3CR1 indicate that the protein structure and residues 249/280 align in a similar conformation (dashed line inside box)
14.11 Å apart, whereas in the variant receptor, I249/M280 residues fall closer within the structure 13.59 Å.

of the total CD45Hi population, was observed in the spinal cord
of mice at peak disease (Figure 6B). Similarly to our observations
in the brain, the severe inflammatory reaction appears to be the
result of macrophages mobilization (Figure 6F), and excessive
extravasation of CD4+ T cells (Figures 6D,F). Flow cytometry
data from brains of EAE mice at chronic disease (Figure 5C)
show a diminished inflammatory state by a reduction on the
overall CD45Hi population across all the genotypes. In contrast,
WT mice exhibit a persistent state of cellular infiltration into
the spinal cord when compared to hCX3CR1I249/M280 mice
(and to CX3CR1-KO to a lesser degree) (Figure 6C). Previous
studies revealed that autoreactive T cells against myelin proteins
play a critical role on disease development during EAE. More
specifically, T cell responses that result in the generation of
IFN-γ secreting Th1 and IL-17 secreting Th17 CD4+ cells are
involved in inflammatory-mediated damage to myelin and
neurons in EAE. The activation of CD4+ T cells is initiated
in peripheral lymph nodes with the binding to the antigenic
peptide on major histocompatibility complex (MHC) class
II and co-stimulatory molecules on antigen presenting cells
(Wlodarczyk et al., 2014). Given that CX3CR1 expression is not
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restricted to CNS microglia, but is also confined to other subsets
of circulating immune cells, we sought to evaluate the effect of
the human CX3CR1 variant in the initiation of immune response
against the MOG peptide during EAE. T cells were isolated
from lymph nodes of actively immunized mice 10 days postMOG35−55 immunization, re-stimulated in vitro and assessed for
their polarization toward Th1 /IFN-γ and Th17 /IL-17 cells using
the cytokine ELISpot immune assay (Figure 6G). Cytokineproducing T cells specific for MOG35−55 antigen were quantified
as spot forming units and compared among WT, CX3CR1-KO
and hCX3CR1I249/M280 genotypes (Figure 6G, top). Peripheral
deficiency or defective CX3CR1-signaling did not have a negative
effect in the priming and generation of pathogenic CD4+ T
cells. Similar to the ELISpot results, IFN-γ and IL-17 producing
CD4+ T cells were detected in the CNS (combined brain and
spinal cord tissues) of mice at peak disease (Supplementary
Figures S2A,B). These cells were harvested and, upon activation
in vitro, showed no evident difference in cytokine production
due to CX3CR1 signaling, supporting the notion that differential
manifestation of EAE symptoms and CNS pathology does not
seem to be the result of altered T cells responses in CX3CR1-KO
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FIGURE 3 | hCX3CR1I249/M280 expressing mice and CX3CR1-KO mice exhibit higher EAE scores. (A) CX3CR1-WT (open circles/bars) CX3CR1-KO (gray
circles/bars) and hCX3CR1I249/M280 mice (black circles/bars) were immunized with MOG35−55 peptide and scored daily for neurological signs. (B) Days of EAE
onset and peak, (C) maximum EAE score, and (D) cumulative disease score. ∗ p < 0.05, ∗∗ p < 0.01. Each dot represents data from an individual mouse.

or hCX3CR1I249/M280 mice. The abundance of T cells in the
spinal cord of EAE mice was consistent with the notion that
CD4+ T cells are the primary drivers of pathological alteration
in this murine model (Figures 6D,E). Pathological data from
MS patients shows that CD8+ T cells may play an important
role in the propagation of the inflammation and tissue damage
(Lassmann and Bradl, 2017). In this regard, it is of major interest
that expression of the human variant CX3CR1I249/M280 receptor
in the mouse genome was correlated with a higher percentage
of CD8+ T cells both at peak and chronic EAE (Figures 6D,E)
providing a relevant foundational argument for the utilization of
these mice as a valid model for human inflammatory diseases of
the CNS.

compared. Due to the enhanced demyelination and neuronal
pathology observed in cerebellar tissues of mice with defective
CX3CR1 signaling, we focused this analysis in cerebellar
regions among the EAE groups after normalization to naïve
tissues (Figure 7A). LCN2 was the most upregulated gene
in hCX3CR1M280 mice displaying a 26.19 fold increase,
accompanied by higher levels in CX3CR1-KO mice (↑91.61)
and WT mice (↑100.64). Increased LCN2 mRNA was validated
at the protein level by immune-detection of LCN2 protein in
brain and spinal cord tissues of EAE mice (Figure 7B). The
immunopositive area was quantified in brain tisues (Figure 7C)
and LCN2+ cells were counted in spinal cord (Figure 7D).
LCN2 levels in naïve tissues are represented in dotted blue line
in respective graphs (Figures 7C,D). Other major upregulated
genes include Ccl5, Cxcl9, Cxcl10, cytochrome b beta (Cybb),
complement component C3 (C3), and CD74. Inflammatory
related genes upregulated in KO mice and with lesser abundance
in hCX3CR1M280 mice include H2-Aa, H2-Ab1, and H2-Eb1.

Differential Transcriptional Profile in the
CNS of EAE Induced Mice
A fundamental concept underlying MS and EAE pathology
is the associated inflammatory reaction, and the interplay
between hematogenous derived cells and resident brain cells
that contribute directly and/or indirectly to demyelination and
axonal damage. In our efforts to further assess differences and
similarities between the response to EAE in WT, CX3CR1-KO
and hCX3CR1M280 mice, we performed NanoString analyses
in which 549 transcripts within the immunology panel were
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Microglia Responses During EAE
Our laboratory and others have shown that FKN regulates
microglia function by inhibiting microglia activation and the
release of inflammatory mediators such as IL-1β. Induction
of EAE results in increased microglia numbers in cerebellar
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FIGURE 4 | CX3CR1I249/M280 and CX3CR1-KO mice reveal increased cerebellar pathology. (A) Brain tissues were subjected to immunohistochemistry with
antibodies against CD45 (brown staining) as a marker of global inflammation (top panels), calbindin to visualize cerebellar Purkinje cells (middle panels) and MBP to
compare demyelination in WT, KO, and hCX3CR1I249/M280 mice (hM280). Scale bars 50 µm, original magnification 20x. (B) Calbindin-positive cells per section,
∗∗ p < 0.01 between naïve WT and hM280 mice and ∗∗∗ p < 0.001 between diseased KO and hM280 compared to WT mice. (C) Myelin immunoreactive area,
p < 0.01 when comparing EAE to corresponding naïve mice, and across the selected groups, ∗∗∗ p < 0.001.

from WT and CX3CR1-KO mice provided evidence for
a role of microglia in myelination, iron trafficking, antiinflammation, and neurogenesis driven by the expression
of CX3CR1 (Figure 8G) as noted by the upregulation of
genes involved in these physiological process only in WT
microglia. In contrast, microglia from mice lacking the CX3CR1
receptor show upregulation of genes involved in inflammatory
processes. Fold change and FDR p-value for significant
genes (upregulated and downregulated) in CX3CR1-WT and
CX3CR1-KO microglia during EAE are found in Supplementary
Tables S1, S2.

tissues (Figures 8A,B) accompanied by changes in cell
morphology, reflected by retraction of cellular processes
and enlargement of the cell body (Figure 8A). Microglia
activation is calculated by measurements of the roundness
of individual cells as depicted by the transformation index
(Figure 8C). Assessment of activation markers by microglia
show an increased expression of MHC-II molecules during
peak EAE, which were found ameliorated during chronic
stages of the disease (Figure 8D). Negligible changes in the
median fluorescence intensity (MFI) for CD11b (Figure 8E)
or CD86 (Figure 8F) were observed in microglia in diseased
mice, suggesting that antigen presentation through MHC-II
is one of the most prominent features of microglia during
EAE. Basal level for activation markers on naïve microglia are
noted in dotted lines (Figures 8D–F). Infiltrating monocytes
(CD45Hi CD11b+ Ly6C+ ) showed increased MFI for MHCII, CD11b, and CD86 only during peak EAE, with values
comparable to naïve microglia by later stages of the disease.
Activation markers on naïve blood macrophages did not show
statistical differences across the genotypes (Supplementary
Figure S3). Further RNA-seq analysis from microglia sorted
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Deficient CX3CR1 Signaling Impairs
Fractalkine and CNTF Production During
EAE
Within the CNS, fractalkine has been proposed to act through
the interaction with its unique CX3CR1 receptor expressed
on microglia to maintain their homeostatic resting state.
We found that basal fractalkine levels detected in soluble
brain and spinal cord extracts of WT mice have a fivefold
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FIGURE 5 | Predominant abundance of CD45Lo CD11b+ cells in hCX3CR1I249/M280 mice at peak phase of disease. (A) Gating strategy of brain mononuclear cells
separated over Percoll gradients at peak and chronic stage of disease. Cells were stained and analyzed by flow cytometry, singlets were gated and cells separated
to distinguish microglia (CD45Lo CD11b+ ), neutrophils (CD45Hi CD11b+ Ly6G+ ), macrophages (CD45Hi CD11b+ Ly6CHi Ly6G− ), monocyte derived DCs
(CD45Hi CD11b+ Ly6G− CD11c+ ) and conventional DCs (CD45Hi CD11b− Ly6G− CD11c+ ). (B–E) Frequency of total infiltrating cells, microglia, and myeloid subsets at
peak and chronic stage of disease are shown, each point represents data from an individual mouse. ∗∗ p < 0.01.

increase during EAE-induced disease (Figure 8H). A sevenfold
increase in fractalkine was observed in naïve CX3CR1-KO
mice in comparison to naïve WT mice, supporting a role
for CX3CR1 as a scavenger receptor (Cardona et al., 2008).
Fractalkine levels in CX3CR1 deficient mice seemed to reach
maximum induction, as neuroinflammation induced by
MOG35−55 immunization did not affected significantly the
levels of detected soluble fractalkine. Similar results were
observed in mice expressing the human CX3CR1I249/M280
variant, which exhibited intermediate fractalkine levels in
naïve conditions that appear sustained upon EAE induction
(Figure 8H). Similar to the effects on fractalkine production,
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we observed impaired production of CNTF in the CNS
of both mouse strains with defective CX3CR1 signaling,
CX3CR1-KO and hCX3CR1I249/M280 mice at chronic
EAE (Figure 8I). Also, the defect on CNTF production
correlated with the significant neuronal cell loss observed
as a result of CX3CR1 dysfunction in CX3CR1-KO and
hCX3CR1I249/M280 mice. To address if IL-1β levels were
differentially regulated in the diseased brain, cytokine
ELISA was performed (Figure 8J), and combined with
IL-1β immunostaining, the data indicate that soluble and
cell-associated IL-1β is increased more abundantly in WT mice
(Figures 8J–L).
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FIGURE 6 | Increased abundance of CD8 T cells in spinal cord tissues of hCX3CR1I249/M280 mice. (A) Gating strategy of spinal cord cell suspensions separated
over Percoll gradients at peak and chronic stages of disease. Cells were stained and analyzed by flow cytometry, singlets were gated and cells separated to
distinguish CD45Hi blood derived inflammatory cells and CD45Lo microglia at peak (B) and chronic stages of disease (C). CD4+ and CD8+ T cells as
CD45Hi CD4+ CD8− and CD45Hi CD4− CD8+ respectively were also compared at peak (D) and chronic (E) stages of EAE. A separate staining cocktail as described
in the data presented in Figure 5 for myeloid subsets was included and frequency of lymphocytes and myeloid populations at peak disease compared (F).
(G) Cytokine ELISpot assay to compare the frequency of IFN-γ and IL-17 producing T cells that are specific for MOG35−55 peptide is shown. ∗ p < 0.05. Each point
represents data from an individual mouse.
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FIGURE 7 | Nanostring gene expression analysis in the cerebellum of EAE induced mice. (A) Quantitative nCounter (Nanostring technologies) expression proofing of
582 immunological-related genes was performed on cerebellar tissues at chronic disease stages from CX3CR1-WT (blue-filled bars), CX3CR1-KO (green-filled bars)
and hCX3CR1I249/M280 mice (red-filled bars). Top upregulated genes are shown. (B) To validate the expression of the top regulated transcript LCN2,
immunohistochemistry was performed. Scale bars 100 µm, original magnification 10x. LCN2 immunoreactive area in brain (C) and cell density in spinal cord tissues
(D) were compared among the groups. Each point represents data from an individual mouse. Dotted blue line represents the basal levels of LCN2 positivity in naïve
tissues.

We showed in vitro that the reference human receptor was
able to signal in response to mouse FKN and induce cell
migration in a dose dependent manner, whereas the variant
hCX3CR1I249/M280 displayed blunted responses, correlating
with published studies that established the adhesive defective
properties of the hCX3CR1I249/M280 (McDermott et al., 2003).
Protein bioinformatic and hypothetical modeling revealed that
the amino acid changes in the variant receptor affect the
hydrophobicity of the protein within the intermembrane region.
The structure within the intramembrane domain did not
appear to differ between the mouse CX3CR1-receptor and
the hCX3CR1V249/T280 reference receptor. However, for the
variant hCX3CR1I249/M280 receptor, these changes also affect
the extracellular loops that contact the ligand. Functionally,
the model was validated by (1) assessing chemotactic responses
toward the mouse FKN in transmigration assays, (2) confirming
homologous recombination of the target construct by Southern
blots using 30 and 50 probes, and (3) comparing CX3CR1
expression at the transcript level in CNS tissues (Figure 1)
across the genotypes, showing that mice expressing the
hCX3CR1I249/M280 variant receptor exhibit CX3CR1 mRNA
levels comparable to WT mice.
Analyses of cellular infiltration revealed comparable
frequencies of IFN-γ and IL-17 MOG35−55 antigen specific
T cells in draining lymph nodes. Similarly, myeloid cell
infiltration and abundance of CD4+ T cells did not reveal
significant differences among CX3CR1-WT, CX3CR1-KO, and

DISCUSSION
Chemokines and their receptors play an important role during
CNS autoimmune inflammation, not only by guiding immune
cell infiltration within demyelinating lesions but also by
promoting a communication system for resident CNS cells. As
an example, FKN and CX3CR1 are abundantly expressed in
the naïve CNS by neurons and microglia respectively. FKN and
CX3CR1 play an important role in brain homeostasis and the
severe phenotype of mice lacking FKN or CX3CR1 in selective
models of neurodegeneration poses a question about the impact
of polymorphic CX3CR1 variants during neuroinflammatory
insults. In this study, we describe the phenotype of mice
expressing the human CX3CR1I249/M280 variant during active
EAE. This novel model shared phenotypic features seen in
EAE-induced CX3CR1-WT and CX3CR1-KO mice. Notable
findings are highlighted by comparable EAE severity and
cerebellar pathology in hCX3CR1I249/M280 and CX3CR1-KO
mice (Figure 4), and abundance of microglia and CD8+ T
cells in hCX3CR1I249/M280 mice (Figure 6). Although this
report does not include a direct comparison to the reference
hCX3CR1V249/TM280 , this humanized system serves as a proof
of principle to validate alternative interventions/therapies to
modulate the inflammatory reaction in the EAE brain with
direct translational relevance to human disease and will provide
valuable information on the function of these polymorphic
receptors in various immune cell types.
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FIGURE 8 | Microglia and effects of CX3CR1/FKN signaling during EAE. (A) Microglia cells were detected by immunohistochemistry staining using anti-Iba-1
antibody in brain tissues of EAE mice and compared to naïve counterparts. Scale bars 50 µm, original magnification 20x. Microglia were counted in cerebellum
sections, ∗∗ p < 0.01 (B) and morphological changes were measured by quantification of transformation index, ∗∗∗ p < 0.001 (C). Activation state of microglia
(CD45Lo CD11b+ ) was also determined by flow cytometry assessment of median fluorescence intensity (MFI) of MHC-II (D), CD11b (E) and CD86 (F), baseline MFI
of microglia in naïve tissues is represented by dotted line (D–F). Microglia sorted based on CD45Lo CD11b+ profile were analyzed through RNA-seq. Table (G) shows
a list of genes significantly upregulated only in CX3CR1-WT or CX3CR1-KO microglia as compared to naïve counter parts. Brain soluble extracts were used to
measure FKN (H), CNTF (I), and IL-1β (J) levels in naïve and diseased mice. IL-1β expression was validated by immunofluorescence staining of cerebellar tissues of
naïve and EAE mice (K,L). ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001.

hCX3CR1I249/M280 groups. However, CD8+ T cell infiltration
appeared to be increased in mice expressing the variant receptor.
Similarly, microglial frequency quantified by flow cytometry
appear increased in hCX3CR1I249/M280 mice. Of interest was the
distinct transcriptional profile of WT versus KO CNS tissues
during the chronic phase of EAE. Using the inflammatory code
set from nanostring technologies, lipocalin 2 (LCN2) was the top
upregulated gene with a higher abundance in both CX3CR1-WT
and CX3CR1-KO tissues compared to hCX3CR1I249/M280 .
Validation at the protein level revealed a similar pattern of
expression in brain tissues in agreement with other EAE studies
(Marques et al., 2012). LCN2 is a multi-functional protein that
plays a role in cell migration (Lee et al., 2011), inflammation
(Nam et al., 2014), neurogenesis (Ferreira et al., 2018), iron
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transport (Srinivasan et al., 2012), and reduction of oxidative
stress (Yamada et al., 2016). The phenotype of LCN2-KO mice
during EAE has produced conflicting results with one study
reporting ameliorated disease after EAE induction (Nam et al.,
2014) and another study showing inhibition of remyelination
by LCN2 in vitro (Al Nimer et al., 2016). The data presented
here suggest that less severe EAE in WT mice correlates with
higher LCN2 levels. Since iron has been proven essential for
progenitor cell proliferation and differentiation (Schonberg and
McTigue, 2009), understanding how FKN directly or indirectly
regulates LCN2 expression in glial cells may provide valuable
insights on ways to enhance neuroprotection. Following up
the overall tissue transcriptional profile, RNA sequencing of
sorted microglia (Figure 8) also revealed several significant
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found that CX3CR1 recruits regulatory NK cells and CX3CR1deficiency exacerbates active EAE disease (Huang et al., 2006).
MS patients revealed lower expression of CX3CR1Hi NK cells in
peripheral blood which correlated with disease activity (InfanteDuarte et al., 2005), and CX3CR1 was required for maturation
of NK cells and a protective role of CX3CR1Hi NK cells via
elimination of autoreactive T cells is proposed (Hamann et al.,
2011; Hertwig et al., 2016). EAE-induced CX3CR1-KO mice
revealed increased infiltration of monocyte derived DCs to the
brain, greater microglia activation and proliferation associated
to areas of enhanced demyelination and neuronal loss (Garcia
et al., 2013). Overall, EAE phenotype in mice expressing the
hCX3CR1I249/M280 variant show higher disease scores, significant
demyelination, decreased cerebellar neuronal counts, higher
CD45Lo CD11b+ , and CD8 T cell densities. Using nanostring
analyses from the top significantly upregulated genes among
WT, KO and hCX3CR1I249/M280 mice, LCN2, Ccl5, Cxcl9 and
genes related to MHC-II antigen processing and presentation
were in lesser abundance in hCX3CR1I249/M280 mice. Previously
published observations support the relevance of FKN/CX3CR1
pathway in CNS pathology, the results in the current study
establish the potential risk of worsening disease severity in
a hCX3CR1I249/M280 expressing host. Future studies guided
to compare microglia, and CD8 T cells responses in mice
alternatives models engineered to express the human reference
and variant CX3CR1 receptors will be critical to validate the data
presented here and will overall provide a better understanding of
the impact of this polymorphic variants in optic nerve pathology
and models of demyelinating disease.

differentially regulated genes, with particular relevance in WT
microglia transcripts involved in myelination (Cd300lf, Lgals3,
Cst7), iron trafficking (LCN2, Ltf), neurogenesis (Bst1), and
anti-inflammatory pathways (Ccl22, Ifitm1, IL1rn). Due to
the expression of IL-1 related transcripts and the association
of IL-1β with microglial neurotoxicity (Cardona et al., 2006)
we assessed protein expression by staining and tissue ELISA
and found that soluble IL-1β is higher in WT tissues with
expression likely restricted to infiltrating immune cells, whereas
in CX3CR1-KO and hCX3CR1I249/M280 mice most IL-1β+
cells colocalized with GFAP+ staining. Also, of relevance is the
observation of decreased CNTF protein levels in CX3CR1-KO
and CX3CR1I249/M280 mice, in particular because CNTF is
widely recognized as a key survival factor not only for neurons
but also for oligodendrocytes (Stankoff et al., 2002; Kuhlmann
et al., 2006; Tebar et al., 2008; Cao et al., 2010). Similar to LCN2,
the mechanisms by which CX3CR1 signaling promote CNTF
production are still to be dissected. Future studies comparing
the transcriptome profile of microglia expressing the reference
and variant receptors would be valuable to better understand
the regulation of microglia by CX3CR1 within the human
population.
The combined actions of genetic and environmental factors
influence susceptibility to autoimmune disease (Reich et al.,
2018). In the context of MS, close to 200 gene variants
that increase the risk of MS have been identified in genome
wide association studies of which the most significant remains
the MHC (Sawcer et al., 2011). Other risk alleles include
inflammation-related mediators. The biology of FKN/CX3CR1
presents various aspects of relevance to the pathology of MS,
including the CX3CR1 and FKN expression pattern. CX3CR1
is expressed by microglia and subpopulations of circulating
monocytes, dendritic cells, T cells, and NK cells. However,
microglia, relative to hematogenous derived cells, express the
highest levels of CX3CR1 (Saederup et al., 2010; Mizutani et al.,
2012). Increased FKN levels are present in cerebrospinal fluid
and serum of patients with relapsing-remitting MS (Kastenbauer
et al., 2003) and comparison of MS and healthy post-mortem
brains revealed the presence of a hypermethylation mark in the
FKN loci that correlated with decreased FKN transcript levels
in demyelinated lesions (Huynh et al., 2014). In a recent study,
it was suggested that the hCX3CR1-M280 mutation associates
with secondary progressive MS (SPMS) in which patients develop
more demyelinated lesions (Stojkovic et al., 2012). Moreover,
CX3CR1 mRNA is present in active MS lesions, although it is
unknown which polymorphic variant was present (Ridderstad
et al., 2014). In a rat EAE model, subcutaneous administration
of high doses of a chemokine inhibitor ameliorated disease
symptoms. However, specificity toward CX3CR1 versus other
chemokine receptors was not defined. Moreover, this study did
not provide characterization of microglial responses, nor CNS
immune subsets to determine if the effects of the inhibitor
were due to influences in peripheral or CNS resident cells
(Ridderstad et al., 2014). CX3CR1+ CD4+ T cells were enriched
in cerebrospinal fluid of relapsing-remitting MS patients (Blauth
et al., 2015) and CX3CR1 appears critical for the development
of CD8 memory T cells (Bottcher et al., 2015). It was also
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combination of linear values including the energy of torsion angles, coupling
energy of atom pairs, energy of solvation, and energy of the beta carbon, values of
secondary structure and values of accessibility of solvent. The model is assigned a
normalized value that estimates the reliability of the model with a range between
0–1. For the selected model the QMEAN6 value of 0.546 as a global parameter
that is accepted when values are above 0.5. (D) The most reliable amino acid
fragments coincide with the regions that are not mobile such as α-helices within
the membrane (Figure 2). Loops are predicted with a disorganized orientation but
with an extracellular configuration that may be involved in ligand-receptor
interaction. The variant protein proposes a shift that affects the extracellular region
leading to disruption in disulfide bridges (C21-C265), generating conformational
changes in the protein structure that alter CX3CR1-ligand recognition domain and
which could potentially negatively affect protein function.
FIGURE S2 | IL-17 and IFN-γ production by CD4+ and CD8+ T cells in EAE
affected mice. (A) Brain and spinal cord mononuclear cells isolated over percoll
gradients were subjected to imaging flow cytometry with gating strategy based on
singlet population, followed by CD4 and CD8 T cell separation and IFN-γ and
IL-17 discrimination. (B) Images show that double positive cells for IFN-γ/IL-17
were less abundant that the single positive counterparts and detected in similar
proportions among the groups.

SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fncel.
2018.00365/full#supplementary-material

FIGURE S3 | Signature profile of brain and blood leukocytes. Activation of brain
and spinal cord microglia (CD45Lo CD11b+ ) and infiltrating macrophages
(CD45Hi CD11b+ Ly6C+ ) was assessed by flow cytometric assessment of median
fluorescence intensity as a representation of abundancy of MHC-II (left panels),
CD11b (middle panels) and CD86 (right panels) molecules. These activation
markers were also evaluated in blood monocytes from naive mice. Microglia
activated phenotype is characterized by increased MHC-II MFI at peak disease,
whereas infiltrating monocytes also exhibit higher MFI for CD11b and
co-stimulatory molecule CD86. Insertion of hCX3CR1I249/M280 does not appear to
affect the peripheral immune populations (bottom panel). Presented p-values
correspond to significant differences between mice of the same phenotype at
peak vs. chronic disease, unless otherwise stated.

FIGURE S1 | Quantitative validation of energetics and stereochemistry. (A) The
proposed structural models were built using the prediction software Phyre2,
Swiss-assessment structure suite that provides energetic values and the
RAMPAGE software that characterizes the stereochemistry of the proposed model
from measurement of dihedral angles with Ramachandran graphics, showing that
89% of the residues fall within the favored region, 6.5% in the allowed region and
4.5% in the outliner region, therefore 95.5% of the residues are within the degree
of acceptance for the QMEAN6/Z score and Ramachandran plot. (B) Comparison
of protein composition based on size given by Z-score values. The feasibility of the
hypothetical model yields a value of −3.81, positioning the model within the X-ray
and NMR area of the graph based on experimental data. (C) Energetic
characterization based on fragments of amino acids along the primary sequence,
first using a central amino acid and obtaining an energetic average in fragments of
10 and 40 amino acids (window size). Values above the ‘zero’ threshold are
considered problematic and coincide within extracellular and intracellular loops
that reflect flexible and disorganized areas that may function as the recognition site
of the ligand fractalkine. Similarly, the QMEAN6 value obtained is derived from a

TABLE S1 | Genes significantly regulated in CX3CR1-WT microglia in comparison
to naïve microglia.
TABLE S2 | Genes significantly regulated in CX3CR1-KO microglia in comparison
to naïve microglia.
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